Reliance Industries Ltd (750634)
Please find attached a media release by Karkinos Healthcare Private Limited, a subsidiary of the Company, titled "Reliance-owned Karkinos Healthcare crosses one lakh HPV DNA tests, strengthening ....
Reliance-owned Karkinos Healthcare completed over 100,000 HPV DNA tests across India, enhancing cervical cancer screening and follow-up care. The program integrates WHO-recommended HPV DNA testing with digital tracking and navigation to ensure women receive diagnosis and treatment after positive results. Diverse implementation models reached underserved communities beyond major cities. The initiative supports India's cervical cancer elimination goals and plans to scale to one million tests next.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 750634 — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add 750634 to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Reliance Industries Ltd
Important.
The summary above is generated automatically from Reliance Industries Ltd's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.